Mesenchymal stem cell therapy in type 2 diabetes mellitus.

Diabetol Metab Syndr · 2017 · PMC5433043 · PMID 28515792

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

also reported an improvement in C-peptide levels at 1 year after MSC implantation, but later there was a decreasing trend in C-peptide levels over the following 2 years [ 73 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.